Synopsys, Inc. (SNPS) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1161315,
    "name": "Synopsys, Inc.",
    "stock_name": "Synopsys, Inc.",
    "full_name": "Synopsys, Inc.",
    "name_url": "stocks-analysis/synopsys-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "463.74",
    "chg": 14.39,
    "chgp": "3.2%",
    "dir": 1,
    "prev_price": "449.35",
    "mcapval": "115,263.30",
    "mcap": "Large Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Software Products",
    "ind_code": 3310,
    "indexname": "S&P 500",
    "isin": "US8716071076",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "3.02 M",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/synopsys-inc-1161315-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Synopsys Stock Hits Day High with Strong 3.2% Intraday Surge",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/synopsys-stock-hits-day-high-with-strong-32-intraday-surge-3749297",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/SynopsysInc_priceRelatedfactors_3749297.png",
        "date": "2025-12-05 16:45:12",
        "description": "Synopsys, Inc. has shown strong recent performance, with a notable increase on December 4, 2025, and a significant rise over the past week. However, the company has faced challenges, reporting negative results for five consecutive quarters and experiencing an annual decline, despite its large market capitalization."
      },
      {
        "title": "Synopsys Stock Hits Day High with Strong 3.8% Intraday Surge",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/synopsys-stock-hits-day-high-with-strong-38-intraday-surge-3747016",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/SynopsysInc_priceRelatedfactors_3747016.png",
        "date": "2025-12-04 16:45:08",
        "description": "Synopsys, Inc. has seen a significant rise in its stock today, outperforming the S&P 500. Over the past week, the company has improved notably, although its year-to-date performance remains negative. Despite recent gains, Synopsys has faced challenges over the past year, reflecting a decline in stock value."
      },
      {
        "title": "Synopsys Stock Soars 7.5%, Hits Intraday High of $453.54",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/synopsys-stock-soars-75-hits-intraday-high-of-45354-3744603",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/SynopsysInc_priceRelatedfactors_3744603.png",
        "date": "2025-12-03 16:40:16",
        "description": "Synopsys, Inc. has seen a notable increase in its stock performance today, contrasting with a slight decline in the S&P 500. While the company has experienced fluctuations over the past year and year-to-date, it maintains a strong market capitalization and a reasonable price-to-earnings ratio, indicating potential for recovery."
      },
      {
        "title": "Synopsys Stock Hits Day High with Strong 6.98% Intraday Surge",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/synopsys-stock-hits-day-high-with-strong-698-intraday-surge-3742096",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/SynopsysInc_priceRelatedfactors_3742096.png",
        "date": "2025-12-02 16:33:35",
        "description": "Synopsys, Inc. saw a notable increase in its stock today, outperforming the broader market. Despite recent gains and a strong weekly performance, the company faces challenges with a year-to-date decline and negative results over the past five quarters, indicating ongoing financial difficulties."
      },
      {
        "title": "Synopsys Stock Hits Day High with Strong 4.19% Intraday Surge",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/synopsys-stock-hits-day-high-with-strong-419-intraday-surge-3729433",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/SynopsysInc_priceRelatedfactors_3729433.png",
        "date": "2025-11-25 16:38:52",
        "description": "Synopsys, Inc. saw a significant increase in its stock price today, contrasting with the S&P 500's modest rise. Despite recent gains, the company has faced challenges, including a notable decline over the past month and year. Its market capitalization stands at USD 115,263 million, with a price-to-earnings ratio of 56.00."
      },
      {
        "title": "Synopsys, Inc. Experiences Revision in Its Stock Evaluation Amidst Competitive Landscape",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/synopsys-inc-sees-valuation-grade-shift-from-expensive-to-very-expensive-3707907",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/SynopsysInc_valuationdot_3707907.png",
        "date": "2025-11-17 15:36:18",
        "description": "Synopsys, Inc. has recently adjusted its valuation, with a P/E ratio of 56 and a price-to-book value of 7.81. The company shows strong operational efficiency, reflected in a high ROCE of 24.32% and ROE of 13.98%. Despite these metrics, Synopsys has struggled with stock performance this year."
      },
      {
        "title": "Is Synopsys, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-synopsys-inc-overvalued-or-undervalued-3689171",
        "imagepath": "",
        "date": "2025-11-11 11:12:38",
        "description": "As of 7 November 2025, the valuation grade for Synopsys, Inc. has moved from very expensive to expensive, indicating a slight improvement but still suggesting overvaluation. The company appears overvalued based on its high valuation ratios, including a P/E ratio of 56, an EV to EBITDA of 42.37, and a Price to Book Value of 7.81. In comparison to peers, Synopsys has a significantly higher P/E ratio than Microsoft Corp. at 36.17 and Oracle Corp. at 51.69, which further supports the notion of overvaluation.\n\nAdditionally, Synopsys has underperformed against the S&P 500 across multiple time frames, with a year-to-date return of -17.43% compared to the S&P 500's 14.40%, and a one-year return of -28.63% versus the S&P 500's 12.65%. This trend reinforces the assessment that the stock is currently overvalued in the market...."
      },
      {
        "title": "Synopsys, Inc. Experiences Revision in Its Stock Evaluation Amidst Market Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/synopsys-inc-sees-valuation-grade-downgrade-from-very-expensive-to-expensive-3686268",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/SynopsysInc_valuationdot_3686268.png",
        "date": "2025-11-10 15:59:13",
        "description": "Synopsys, Inc. has recently adjusted its valuation, showcasing a P/E ratio of 56 and a price-to-book value of 7.81. Despite facing challenges with a year-to-date return of -18.94%, the company has demonstrated resilience over three years, although it lags behind the S&P 500 and peers like Microsoft and Salesforce."
      },
      {
        "title": "Is Synopsys, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-synopsys-inc-overvalued-or-undervalued-3685013",
        "imagepath": "",
        "date": "2025-11-10 11:13:51",
        "description": "As of 7 November 2025, the valuation grade for Synopsys, Inc. has moved from very expensive to expensive, indicating a shift in its perceived value. The company appears overvalued based on its current metrics, with a P/E ratio of 56, a Price to Book Value of 7.81, and an EV to EBITDA of 42.37. In comparison, peers such as Microsoft Corp. and Oracle Corp. have P/E ratios of 36.17 and 51.69, respectively, suggesting that Synopsys is trading at a premium relative to its industry counterparts.\n\nRecent performance shows that Synopsys has underperformed against the S&P 500, with a year-to-date return of -18.94% compared to the index's 14.40%. This trend is further highlighted by a one-year return of -31.41% versus the S&P 500's 12.65%, reinforcing the notion that the stock may be overvalued in the current market environment...."
      }
    ],
    "total": 36,
    "sid": "1161315",
    "stock_news_url": "https://www.marketsmojo.com/news/synopsys-inc-1161315"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Synopsys Stock Hits Day High with Strong 3.2% Intraday Surge

2025-12-05 16:45:12

Synopsys, Inc. has shown strong recent performance, with a notable increase on December 4, 2025, and a significant rise over the past week. However, the company has faced challenges, reporting negative results for five consecutive quarters and experiencing an annual decline, despite its large market capitalization.

Synopsys Stock Hits Day High with Strong 3.8% Intraday Surge

2025-12-04 16:45:08

Synopsys, Inc. has seen a significant rise in its stock today, outperforming the S&P 500. Over the past week, the company has improved notably, although its year-to-date performance remains negative. Despite recent gains, Synopsys has faced challenges over the past year, reflecting a decline in stock value.

Synopsys Stock Soars 7.5%, Hits Intraday High of $453.54

2025-12-03 16:40:16

Synopsys, Inc. has seen a notable increase in its stock performance today, contrasting with a slight decline in the S&P 500. While the company has experienced fluctuations over the past year and year-to-date, it maintains a strong market capitalization and a reasonable price-to-earnings ratio, indicating potential for recovery.

Synopsys Stock Hits Day High with Strong 6.98% Intraday Surge

2025-12-02 16:33:35

Synopsys, Inc. saw a notable increase in its stock today, outperforming the broader market. Despite recent gains and a strong weekly performance, the company faces challenges with a year-to-date decline and negative results over the past five quarters, indicating ongoing financial difficulties.

Synopsys Stock Hits Day High with Strong 4.19% Intraday Surge

2025-11-25 16:38:52

Synopsys, Inc. saw a significant increase in its stock price today, contrasting with the S&P 500's modest rise. Despite recent gains, the company has faced challenges, including a notable decline over the past month and year. Its market capitalization stands at USD 115,263 million, with a price-to-earnings ratio of 56.00.

Synopsys, Inc. Experiences Revision in Its Stock Evaluation Amidst Competitive Landscape

2025-11-17 15:36:18

Synopsys, Inc. has recently adjusted its valuation, with a P/E ratio of 56 and a price-to-book value of 7.81. The company shows strong operational efficiency, reflected in a high ROCE of 24.32% and ROE of 13.98%. Despite these metrics, Synopsys has struggled with stock performance this year.

Is Synopsys, Inc. overvalued or undervalued?

2025-11-11 11:12:38

As of 7 November 2025, the valuation grade for Synopsys, Inc. has moved from very expensive to expensive, indicating a slight improvement but still suggesting overvaluation. The company appears overvalued based on its high valuation ratios, including a P/E ratio of 56, an EV to EBITDA of 42.37, and a Price to Book Value of 7.81. In comparison to peers, Synopsys has a significantly higher P/E ratio than Microsoft Corp. at 36.17 and Oracle Corp. at 51.69, which further supports the notion of overvaluation. Additionally, Synopsys has underperformed against the S&P 500 across multiple time frames, with a year-to-date return of -17.43% compared to the S&P 500's 14.40%, and a one-year return of -28.63% versus the S&P 500's 12.65%. This trend reinforces the assessment that the stock is currently overvalued in the market....

Synopsys, Inc. Experiences Revision in Its Stock Evaluation Amidst Market Challenges

2025-11-10 15:59:13

Synopsys, Inc. has recently adjusted its valuation, showcasing a P/E ratio of 56 and a price-to-book value of 7.81. Despite facing challenges with a year-to-date return of -18.94%, the company has demonstrated resilience over three years, although it lags behind the S&P 500 and peers like Microsoft and Salesforce.

Is Synopsys, Inc. overvalued or undervalued?

2025-11-10 11:13:51

As of 7 November 2025, the valuation grade for Synopsys, Inc. has moved from very expensive to expensive, indicating a shift in its perceived value. The company appears overvalued based on its current metrics, with a P/E ratio of 56, a Price to Book Value of 7.81, and an EV to EBITDA of 42.37. In comparison, peers such as Microsoft Corp. and Oracle Corp. have P/E ratios of 36.17 and 51.69, respectively, suggesting that Synopsys is trading at a premium relative to its industry counterparts. Recent performance shows that Synopsys has underperformed against the S&P 500, with a year-to-date return of -18.94% compared to the index's 14.40%. This trend is further highlighted by a one-year return of -31.41% versus the S&P 500's 12.65%, reinforcing the notion that the stock may be overvalued in the current market environment....

View All News